Chronic Kidney Disease Management: A Survival Guide from Dialysis to Transplantation

Introduction

When chronic kidney disease (CKD) progresses to end-stage (eGFR < 15 ml/min/1.73m²), kidney function is almost completely lost, and patients face two life-sustaining treatment options: dialysis or kidney transplantation. Dialysis is life support, but long-term dialysis (over 5 years) is associated with a cardiovascular mortality rate as high as 40%, whereas successful transplantation offers a 1-year survival rate exceeding 95%, a 5-year survival rate exceeding 80%, and significantly better quality of life compared to dialysis. However, the journey from dialysis dependence to kidney transplantation is a challenging path, involving multiple stages including medical evaluation, surgical risks, and immunosuppression management. This article aims to outline this path for international patients, providing professional and practical guidance.

Dialysis Types: Choices and Survival Data

Dialysis is divided into hemodialysis (HD) and peritoneal dialysis (PD). Hemodialysis typically requires 3 sessions per week, each lasting 4 hours, performed at a dialysis center, and relies on vascular access (arteriovenous fistula or central venous catheter). Peritoneal dialysis uses the patient's own peritoneum as a filter, requiring 4-5 fluid exchanges daily, can be performed at home, and better preserves residual kidney function. A meta-analysis showed that in the early phase of dialysis (first 2 years), patients on peritoneal dialysis had slightly higher survival rates than those on hemodialysis, but after 2 years, there was no significant difference between the two. The choice of dialysis modality should consider factors such as the patient's vascular condition, home support, and occupational needs. For patients awaiting transplantation, peritoneal dialysis may offer a more flexible schedule, while hemodialysis centers provide more comprehensive monitoring. Regardless of the choice, dialysis adequacy directly impacts survival, such as Kt/V ≥ 1.2 (hemodialysis) or weekly total Kt/V ≥ 1.7 (peritoneal dialysis).

Kidney Transplant Evaluation: Are You Suitable for Transplantation?

Kidney transplantation is the optimal treatment for end-stage renal disease, but not all patients are suitable candidates. The transplant evaluation includes comprehensive medical tests: cardiac function (echocardiography, stress testing), vascular assessment (carotid and lower extremity vascular ultrasound), infection screening (hepatitis B, hepatitis C, HIV, EBV, CMV), malignancy screening (chest CT, abdominal ultrasound, tumor markers), psychological evaluation, and social support assessment. The upper age limit varies by center, but generally, patients under 70 years old without severe comorbidities (such as recent malignancy, active infection, or irreversible cardiovascular or cerebrovascular disease) are considered. Absolute contraindications include active tuberculosis, uncontrolled HIV infection, and advanced malignancy. Relative contraindications require individualized consideration, such as diabetes or obesity (BMI > 35). The evaluation process typically takes 4-8 weeks and involves consultations with multiple specialists. International patients need to provide complete medical records and may need to undergo some tests again in China.

Transplant Surgery and Donor Kidney Options: Living Donor or Deceased Donor?

Kidney transplant surgery is relatively mature, with an operative time of about 3 hours and a hospital stay of approximately 7-14 days. There are two sources of donor kidneys: living donors (relatives or spouses) and deceased donors (waiting for allocation from the organ pool). Living donor kidney transplantation offers clear advantages: surgery can be planned in advance, shorter dialysis duration, fewer post-operative complications, and longer graft survival (half-life of living donor grafts is approximately 15-20 years, compared to 10-15 years for deceased donor grafts). In China, living donor kidney transplantation requires strict review by the ethics committee and is limited to relatives within three generations or spouses (married for at least 3 years). Organ pool allocation is based on blood type compatibility, HLA matching, panel reactive antibody (PRA) levels, and waiting time. For international patients, living donor kidney transplantation in China is relatively convenient, while waiting for a deceased donor may take a longer time (average 3-5 years), unless in urgent situations. For patients unable to undergo living donor transplantation, international patients may consider organ pools in other countries, but should be aware of legal regulations and medical safety issues.

Post-Operative Management: Immunosuppression and Long-Term Survival

Long-term success after transplantation depends on meticulous management of the immunosuppressive regimen. The standard protocol is triple therapy: calcineurin inhibitors (e.g., tacrolimus), antiproliferative agents (e.g., mycophenolate mofetil), and corticosteroids. The target trough level of tacrolimus is 5-10 ng/ml in the first 3 months post-surgery, then reduced to 5-8 ng/ml. Infection is a major risk in the early post-transplant period, especially CMV and BK virus, requiring regular monitoring (every 2-4 weeks for the first 6 months). Cardiovascular events are the leading cause of death in late transplant patients, necessitating strict control of blood pressure (<130/80 mmHg), lipids (LDL < 2.6 mmol/L), and blood glucose (HbA1c < 7%). Transplant kidney function should be monitored regularly (creatinine, eGFR, proteinuria), and attention should be paid to drug side effects, such as tacrolimus nephrotoxicity and diabetes risk. Patients require lifelong follow-up, and adherence is crucial; irregular medication can lead to acute rejection and even graft loss.

Advice for International Patients

For international patients considering kidney transplantation in China, the following recommendations may be helpful:

Plan Ahead: Initiate transplant evaluation before or early in dialysis, as the evaluation process is complex, and earlier transplantation leads to better outcomes.

Bring Complete Medical Records: Including previous dialysis records, primary disease diagnosis, comorbidity treatment history, imaging data, and pathology slides (if available).

Understand Legal and Ethical Requirements: China has strict regulations on living donor transplantation; ensure proof of relationship and prepare relevant notarized documents.

Choose an Experienced Transplant Center: Focus on the center's annual surgical volume, graft survival rates, and experience in managing international patients.

Budget Management: The total cost of kidney transplantation (including pre-operative evaluation, surgery, hospitalization, and post-operative immunosuppressants) varies by region, roughly ranging from 300,000 to 600,000 RMB. You can refer to the cost estimator tool or contact us via contact for specific quotes.

Post-Operative Follow-Up: International patients need to plan a long-term follow-up strategy, which may include staying in China for 3-6 months to stabilize, then coordinating care with local physicians after returning home.

On the medical services page, you can find more detailed information about kidney transplantation. We hope every patient can step out of the shadow of dialysis and embrace a healthy future under the guidance of a professional team.